Y. Kurogi

发表

Pharmacophore modeling and three-dimensional database searching for drug design using catalyst.

Y. Kurogi, O. Güner, 2001, Current medicinal chemistry.

Pharmacophore modeling and three dimensional database searching for drug design using catalyst: recent advances.

Osman Güner, Omoshile Clement, Y. Kurogi, 2004, Current medicinal chemistry.

1,2,4-Triazolo[5,1-i]purine derivatives as highly potent and selective human adenosine A(3) receptor ligands.

Y. Kurogi, Y. Nagao, H. Fujiwara, 2002, Journal of medicinal chemistry.

Calculation of nuclear spin–spin couplings. X. Analytical derivative method of perturbation energy

Y. Kurogi, H. Fukui, T. Baba, 2000 .

Rapid Identification of the Hepatic Cytochrome P450 2C19 Activity Using a Novel and Noninvasive [13C]Pantoprazole Breath Test

Lang Li, Y. Kurogi, D. Flockhart, 2009, Journal of Pharmacology and Experimental Therapeutics.

Rapid identification of the hepatic cytochrome P450 (CYP) 2C19 activity using a novel and noninvasive [13C]-pantoprazole breath test

Y. Kurogi, Z. Desta, S. Lemler, 2009 .

Synthesis, properties, and complexation of a new imidazole-pendant macrocyclic 12-membered triamine ligand

Y. Kurogi, E. Kimura, M. Shionoya, 1991 .

A new tetradentate (N−)2S2 macrocyclic ligand which is highly selective for platinum(II) and palladium(II)

Y. Kurogi, E. Kimura, M. Shionoya, 1989 .

Structure-activity relationships of adenosine A3 receptor ligands: new potential therapy for the treatment of glaucoma.

Y. Kurogi, Y. Nagao, H. Nishikawa, 2004, Bioorganic & medicinal chemistry letters.

Synthesis and Hypolipidemic Activities of Novel 2-(4-(( Diethoxyphosphoryl)methyl)phenyl)quinazolines and 4(3H)-Quinazolines.

Y. Kurogi, Y. Tsuda, K. Tsutsumi, 1996 .

Synthesis and hypolipidemic activities of novel 2-[4-[diethoxyphosphoryl)methyl]phenyl]quinazolines and 4(3H)-quinazolinones.

Y. Kurogi, Y. Tsuda, H. Yoshitsugu, 1996, Journal of medicinal chemistry.

Gold(III)-cyclam complexes. X-ray crystal structure and a useful macrocyclic effect on the reduction of gold(III)

Y. Kurogi, T. Koike, E. Kimura, 1993 .

ASYMMETRIC SYNTHESIS OF A XANTHINE DEHYDROGENASE INHIBITOR (S)-(-)-BOF-4272 : MECHANISM OF CHIRAL DIARYL SULFOXIDE FORMATION

Y. Kurogi, N. Fukuda, K. Hashimoto, 1997 .

pH-dependent coordination mode of new bleomycin synthetic analogues with copper(II), iron(II), and zinc(II)

Y. Kurogi, E. Kimura, M. Shionoya, 1992 .

The First Gold(III) Macrocyclic Polyamine Complexes and Application to Selective Gold(III) Uptake.

Y. Kurogi, E. Kimura, Toshiaki Takahashi, 1992 .

The first gold(III) macrocyclic polyamine complexes and application to selective gold(III) uptake

Y. Kurogi, E. Kimura, Toshiaki Takahashi, 1991 .

Mesangial cell proliferation inhibitors for the treatment of proliferative glomerular disease

Y. Kurogi, 2003, Medicinal research reviews.

Facile synthesis of fused 1,2,4-triazolo[1,5-c]pyrimidine derivatives as human adenosine A3 receptor ligands.

Y. Kurogi, Y. Nagao, H. Nishikawa, 2004, Bioorganic & medicinal chemistry letters.

Discovery of novel mesangial cell proliferation inhibitors using a three-dimensional database searching method.

Y. Kurogi, Y Kurogi, K Miyata, 2001, Journal of medicinal chemistry.

Design of discriminating hosts for noble metal ions with double functions of thia and amide donors in macrocyclic structures

Mitsuhiko Shionoya, Eiichi Kimura, Motoo Shiro, 1991 .